Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.77 Analyst target: $6.70 Upside: 771.03%
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. The company is headquartered in Branford, Connecticut.
See the full interactive analysis & chart →Informational only — not investment advice.